Category: Press Release

GIOSTAR Announces FDA Approval Under Compassionate Use to Treat COVID-19 Patients with Stem Cells Brunette Man Wearing Surgical Mask

GIOSTAR Announces FDA Approval Under Compassionate Use to Treat COVID-19 Patients with Stem Cells

Groundbreaking research provides a promising potential alternative to manage devastating pandemic Global Institute of Stem Cell Therapy and Research (GIOSTAR) is pleased to announce that they have received an approval for the emergency use of stem cell therapy to treat acute inflammation of the lungs in [...]
GIOSTAR Launches Stem Cell / Cancer Research and Therapy Center in Chandigarh, India GIOSTAR Chandigarh | Office

GIOSTAR Launches Stem Cell / Cancer Research and Therapy Center in Chandigarh, India

GIOSTAR has played a pivotal role in regenerative medicine in India for many years. This trend continues with the launch of a new stem cell / cancer research and therapy center in Chandigarh, one of the country’s most prestigious cities.

GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial

GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial

For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.